U.S. equity markets raced higher Wednesday after drugmakers reported progress in developing a COVID-19 vaccine while investors looked past dour employment figures as Congress worked toward another economic relief package.

The Dow Jones Industrial Average gained 170 points, or 0.64 percent, in the opening minutes of trading while the S&P 500 and the Nasdaq Composite rose 0.4 percent and 0.18 percent, respectively. The early advance had the Nasdaq on track for its 31st record-high close this year.

The ADP report for July showed private employers added 167,000 jobs in July, well short of the 1.5 million that analysts surveyed by Reifintiiv were anticipating. The ADP reading sets the stage for the July jobs report, which is due out on Friday morning.

Looking at stocks, Johnson & Johnson reached a more than $1 billion deal with the U.S. government to supply 100 million doses of its Janssen Pharmaceutical Companies’ experimental COVID-19 vaccine for use in the U.S. once regulators approve.

A Phase 1 clinical trial of drug maker Novavax, Inc.’s experimental COVID-19 vaccine was generally well-tolerated and induced antibodies in 100 percent of participants.

On the deal front, telehealth marketer Teladoc Inc. has agreed to an $18.5 billion purchase of Livongo Health Inc.; it plans to pay $11.33 cash and 0.592 Teladoc shares for each Livongo share.

Looking at earnings, Dow component Walt Disney Co. reported revenue plunged 42 percent in the three months through June as COVID-19 shuttered its theme parks and postponed movie releases. While sales fell short of Wall Street estimates, profit outpaced expectations. Read more at FOX Business